1.1 Survival |
2 |
397 |
Hazard Ratio (IV, Random, 95% CI) |
0.60 [0.43, 0.82] |
1.1.1 Overall survival |
1 |
203 |
Hazard Ratio (IV, Random, 95% CI) |
0.56 [0.37, 0.87] |
1.1.2 Disease‐specific survival |
1 |
194 |
Hazard Ratio (IV, Random, 95% CI) |
0.64 [0.40, 1.04] |
1.2 Survival: women with carcinomatosis (upfront surgery) |
2 |
|
Hazard Ratio (IV, Random, 95% CI) |
0.61 [0.44, 0.85] |
1.2.1 Overall survival |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
0.58 [0.35, 0.96] |
1.2.2 Disease‐specific survival |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
0.64 [0.41, 0.98] |
1.3 Progression‐free survival |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
1.3.1 Upfront primary debulking surgery |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
1.4 Progression‐free survival: women with carcinomatosis (upfront surgery) |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Subtotals only |
1.5 Disease‐free survival |
1 |
527 |
Hazard Ratio (IV, Random, 95% CI) |
1.60 [1.11, 2.31] |
1.5.1 Mix of upfront and interval debulking surgical procedures – including group 2A |
1 |
258 |
Hazard Ratio (IV, Random, 95% CI) |
1.54 [0.91, 2.60] |
1.5.2 Mix of upfront and interval debulking surgical procedures – including group 2B |
1 |
269 |
Hazard Ratio (IV, Random, 95% CI) |
1.66 [1.00, 2.78] |